Meningococcal vax market to reach $3.8B by 2019; Gates funds $1.4B vaccine cooler grant;

> The market for meningococcal vaccines should reach $3.76 billion globally in 2019, a new report says. Release

> The Bill & Melinda Gates Foundation has granted $1.4 billion to The Sure Chill Company, which is developing a vaccine cooler that can go without power for more than 35 days. More

> Vaxart has appointed John Harland as its CFO. Release

> New follow-up data from Novavax ($NVAX) suggest its RSV vaccine may warrant annual boosts. More

> African governments have pledged $700 million to fund vaccine purchase between 2016 and 2020. Report

And Finally... The Federal Circuit last week refused to take up a woman's case against the U.S. Department of Health and Human Services claiming her son's autism was caused by vaccines. More (sub. req.)